P183 A Pivotal Phase III Randomized Clinical Trial to Evaluate the Safety and Efficacy of the Fluorescent Imaging Agent PD G 506 A for the Real-time Visualization of Cancer During Breast Conserving Surgery. (April 2023) - Mamounas, E.; Feldman, S.; Zaremba, N.; Eisenberg, R.; Lanjewar, S.; Zeuhl, F.; Henry, D.; McEvoy, M.; Pastoriza, J.; Shihabi, A.; Witten, M.; Kepple, J.; et al.